Cargando…

Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals

BACKGROUND: SARS-CoV2 infection has been associated to a wide range of clinical scenarios, named COVID-19, ranging from acute respiratory distress syndrome to blood coagulation abnormalities and vascular manifestations related to hyper-inflammation. Recent focus has been addressed to study of microv...

Descripción completa

Detalles Bibliográficos
Autores principales: Malerba, P, Agabiti Rosei, C, Nardin, M, Gaggero, A, Chiarini, G, Rossini, C, Fama', F, Brami, V, Coschignano, M A, Muiesan, M L, Rizzoni, D, De Ciuceis, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767633/
http://dx.doi.org/10.1093/eurheartj/ehab724.3387
_version_ 1784634777215696896
author Malerba, P
Agabiti Rosei, C
Nardin, M
Gaggero, A
Chiarini, G
Rossini, C
Fama', F
Brami, V
Coschignano, M A
Muiesan, M L
Rizzoni, D
De Ciuceis, C
author_facet Malerba, P
Agabiti Rosei, C
Nardin, M
Gaggero, A
Chiarini, G
Rossini, C
Fama', F
Brami, V
Coschignano, M A
Muiesan, M L
Rizzoni, D
De Ciuceis, C
author_sort Malerba, P
collection PubMed
description BACKGROUND: SARS-CoV2 infection has been associated to a wide range of clinical scenarios, named COVID-19, ranging from acute respiratory distress syndrome to blood coagulation abnormalities and vascular manifestations related to hyper-inflammation. Recent focus has been addressed to study of microvascular alterations which may explain COVID-19 pathophysiology. Alterations in microvascular structure, identified as increased wall to lumen ratio (WLR) of retinal arterioles, have been extensively described in patients with cardiovascular diseases, such as hypertension or diabetes mellitus. Both inflammation and immune system dysregulation seem to play a role in the pathogenesis of these morphological changes. PURPOSE: Aim of this study was to evaluate through Adaptive Optics microvascular differences of retinal arterioles between patients experienced COVID-19 and controls. METHODS: Patients were hospitalized between 28th February and 15th April at a Internal Medicine ward in a tertiary care hospital. All patients tested positive for a SARS-CoV-2 nasopharyngeal swab at admission and showed signs of pneumonia and respiratory insufficiency. Adaptive Optics, which allows a non-invasive evaluation of retinal arteriole structure, and blood chemistry exams were performed as part of follow up visits between 2 to 3 months after hospitalization. Baseline characteristics were collected through medical records. COVID-19 patients were compared to age- and sex-matched healthy subjects referred to our center between 2018 and 2019. RESULTS: A total of 80 patients were included in this study (of which 40 were COVID-19 patients). Apart from smoking habit, other baseline characteristics (sex, age, cardiovascular risk factors and main comorbidities) did not differ between the two groups. At follow up visit COVID-19 patients showed lower values for leukocytes (6.2 vs. 7.5x10(3)/μL, p=0.015) and lymphocytes (1.9 vs. 2.8x10(3)/μL, p=0.002). Creatinine values were higher in patients who suffered from COVID-19 (1.0 vs 0.8 mg/dl, p=0.004 – Figure 1, panel A). Adaptive Optics showed no differences in terms of internal lumen, wall thickness and WLR of retinal arterioles. However, the wall cross-sectional area (WCSA) was found to be higher in COVID-19 patients (p=0.039 – Figure 1, panel B). Hypertension significantly affected both WCSA and WLR between COVID-19 and healthy individuals, while diabetes only impacted on WLR (Figure 2). CONCLUSION: Previous studies described the presence of leukopenia and lymphopenia during the acute phase of SARS-CoV2 infection. Our study demonstrates that these alterations persist several weeks after symptoms onset. Adaptive Optics showed microvascular alterations occurring in these patients: in particular, higher wall cross-sectional area of retinal arterioles were observed in patients after COVID-19 hospitalization, reflecting the complex pathogenic mechanisms which may explain the wide range of symptoms and clinical severity. FUNDING ACKNOWLEDGEMENT: Type of funding sources: None.
format Online
Article
Text
id pubmed-8767633
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-87676332022-01-20 Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals Malerba, P Agabiti Rosei, C Nardin, M Gaggero, A Chiarini, G Rossini, C Fama', F Brami, V Coschignano, M A Muiesan, M L Rizzoni, D De Ciuceis, C Eur Heart J Abstract Supplement BACKGROUND: SARS-CoV2 infection has been associated to a wide range of clinical scenarios, named COVID-19, ranging from acute respiratory distress syndrome to blood coagulation abnormalities and vascular manifestations related to hyper-inflammation. Recent focus has been addressed to study of microvascular alterations which may explain COVID-19 pathophysiology. Alterations in microvascular structure, identified as increased wall to lumen ratio (WLR) of retinal arterioles, have been extensively described in patients with cardiovascular diseases, such as hypertension or diabetes mellitus. Both inflammation and immune system dysregulation seem to play a role in the pathogenesis of these morphological changes. PURPOSE: Aim of this study was to evaluate through Adaptive Optics microvascular differences of retinal arterioles between patients experienced COVID-19 and controls. METHODS: Patients were hospitalized between 28th February and 15th April at a Internal Medicine ward in a tertiary care hospital. All patients tested positive for a SARS-CoV-2 nasopharyngeal swab at admission and showed signs of pneumonia and respiratory insufficiency. Adaptive Optics, which allows a non-invasive evaluation of retinal arteriole structure, and blood chemistry exams were performed as part of follow up visits between 2 to 3 months after hospitalization. Baseline characteristics were collected through medical records. COVID-19 patients were compared to age- and sex-matched healthy subjects referred to our center between 2018 and 2019. RESULTS: A total of 80 patients were included in this study (of which 40 were COVID-19 patients). Apart from smoking habit, other baseline characteristics (sex, age, cardiovascular risk factors and main comorbidities) did not differ between the two groups. At follow up visit COVID-19 patients showed lower values for leukocytes (6.2 vs. 7.5x10(3)/μL, p=0.015) and lymphocytes (1.9 vs. 2.8x10(3)/μL, p=0.002). Creatinine values were higher in patients who suffered from COVID-19 (1.0 vs 0.8 mg/dl, p=0.004 – Figure 1, panel A). Adaptive Optics showed no differences in terms of internal lumen, wall thickness and WLR of retinal arterioles. However, the wall cross-sectional area (WCSA) was found to be higher in COVID-19 patients (p=0.039 – Figure 1, panel B). Hypertension significantly affected both WCSA and WLR between COVID-19 and healthy individuals, while diabetes only impacted on WLR (Figure 2). CONCLUSION: Previous studies described the presence of leukopenia and lymphopenia during the acute phase of SARS-CoV2 infection. Our study demonstrates that these alterations persist several weeks after symptoms onset. Adaptive Optics showed microvascular alterations occurring in these patients: in particular, higher wall cross-sectional area of retinal arterioles were observed in patients after COVID-19 hospitalization, reflecting the complex pathogenic mechanisms which may explain the wide range of symptoms and clinical severity. FUNDING ACKNOWLEDGEMENT: Type of funding sources: None. Oxford University Press 2021-10-14 /pmc/articles/PMC8767633/ http://dx.doi.org/10.1093/eurheartj/ehab724.3387 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Abstract Supplement
Malerba, P
Agabiti Rosei, C
Nardin, M
Gaggero, A
Chiarini, G
Rossini, C
Fama', F
Brami, V
Coschignano, M A
Muiesan, M L
Rizzoni, D
De Ciuceis, C
Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title_full Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title_fullStr Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title_full_unstemmed Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title_short Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals
title_sort early microvascular modifications in patients previously hospitalized for covid-19: comparison with healthy individuals
topic Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767633/
http://dx.doi.org/10.1093/eurheartj/ehab724.3387
work_keys_str_mv AT malerbap earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT agabitiroseic earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT nardinm earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT gaggeroa earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT chiarinig earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT rossinic earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT famaf earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT bramiv earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT coschignanoma earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT muiesanml earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT rizzonid earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals
AT deciuceisc earlymicrovascularmodificationsinpatientspreviouslyhospitalizedforcovid19comparisonwithhealthyindividuals